Sign up to save your podcasts
Or
Share 30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 22 Clinical Trial Design Nuances for Cannabinoid Therapies
This podcast episode explores the complexities and challenges of clinical trials for cannabinoid therapies. The discussion covers key aspects including:
- Dosing variability and product consistency challenges in plant-derived compounds
- Patient compliance and addressing stigma around cannabis research
- Placebo control difficulties unique to cannabinoid studies
- Special considerations for vulnerable populations like children and pregnant women
The episode also examines promising therapeutic applications including chronic pain management, multiple sclerosis treatment, and potential cancer-related applications.
View all episodes
By Jim Mitchell and Google NotebookLMThis podcast episode explores the complexities and challenges of clinical trials for cannabinoid therapies. The discussion covers key aspects including:
- Dosing variability and product consistency challenges in plant-derived compounds
- Patient compliance and addressing stigma around cannabis research
- Placebo control difficulties unique to cannabinoid studies
- Special considerations for vulnerable populations like children and pregnant women
The episode also examines promising therapeutic applications including chronic pain management, multiple sclerosis treatment, and potential cancer-related applications.